Tirzepatide Research Overview
- Popular Name
- Dual GIP And GLP-1 Agonist
- Category
- Weight Loss & Metabolism
- Evidence Tier
- Approved Drug
- Class
- Dual GIP/GLP-1 receptor co-agonist (twincretin); synthetic 39-residue peptide with C18 fatty diacid for albumin binding
- Primary Target
- GIPR (GIP receptor) + GLP-1R (GLP-1 receptor); dual incretin axis activation; pancreatic insulin secretion and hypothalamic appetite suppression
- Half-Life
- ~1 week
- PubMed Citations
- 2,280
- Active Trials
- 174
Mechanism Of Action
It is a dual GIP and GLP-1 receptor agonist. It dramatically slows gastric emptying and sensitizes the body to insulin, resulting in profound appetite suppression and record-breaking weight loss in trials.
Studied For
Type 2 diabetes managementChronic weight management / obesityObstructive sleep apnea in obesity (FDA approved 2024)Non-alcoholic fatty liver disease (NAFLD/MASH)Cardiovascular risk reductionHbA1c loweringBody weight reduction superior to semaglutideInsulin resistance
Sourcing Tirzepatide In The Long Island area
Pep Nation Lab supplies research-grade Tirzepatide to verified researchers across Port Jefferson, NY, in Suffolk County and the wider Long Island area. Every Tirzepatide order ships nationwide with full batch COA documentation, strictly for in vitro laboratory use.
- Service Area
- Port Jefferson, NY (Long Island)
- County
- Suffolk County, New York
- ZIP Codes Served
- 11777
- Shipping
- Nationwide To All 50 States, Including New York
- Compound
- Tirzepatide (Dual GIP And GLP-1 Agonist)
- Documentation
- Batch COA Included With Every Order
- Intended Use
- In Vitro Laboratory Research Only
Tirzepatide In Port Jefferson - Common Questions
More Research Compounds In Port Jefferson
BPC-157 In Port JeffersonTB-500 In Port JeffersonSemaglutide In Port JeffersonRetatrutide In Port JeffersonAll Peptides In Port Jefferson›
Tirzepatide In Nearby Cities

